CJRB-102

N/A

Report date: 2024/10/30 11:26:21

Base Information

Drug NameCJRB-102
Drug Alias NameMRx-0518MRx-518CJRB-102
ClassificationNatural product/Extract > Microbial extractBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell Lung +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlycostem
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies4d Pharma Plc
Active IndicationsN/A
Inactive IndicationsSolid tumoursUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell Lung +[8] 

Other Information

ATC CodeN/A
Related LinksN/A